• Samuel W Lovibond, Morris Odell, and Justin A Mariani.
• Heart Centre, Melbourne, Victoria, Australia.
• Intern Med J. 2020 Mar 1; 50 (3): 271-277.

AbstractAustralian Driving Guidelines for patients with pacemakers and implanted cardioverter defibrillators are in line with many around the world, with some minor differences. Some aspects of these guidelines lack contemporary evidence in key decision-making areas and make broad recommendations regarding groups with heterogeneous populations. In addition, more recent studies suggest lower rates of adverse events in some patients with these devices than previously thought. Through a systematic literature review, along with discussion of current guidelines, we combine new evidence with well established risk assessment tools to ask the following questions: (i) Given the heterogeneity of patient risk within the defibrillator population, should guidelines allow for further individualisation of risk and subsequent licensing restrictions?; and (ii) Could some patients with primary prevention automated cardioverter defibrillators be able to hold a commercial driving licence?© 2019 Royal Australasian College of Physicians.

13 keywords...

hide…